Yayın:
Mast cells, vasoactive intestinal peptide (VIP), and the hemorrhagic shock: a possible relationship?

dc.contributor.authorTunçel, Neşe
dc.contributor.orcid0000-0003-2700-5840
dc.date.accessioned2025-11-13T12:16:17Z
dc.date.issued1993-12-31
dc.identifier.doihttps://doi.org/10.14748/bmr.v2.210
dc.identifier.endpage37
dc.identifier.issn1310-392X
dc.identifier.issue0
dc.identifier.openalexW2044069699
dc.identifier.startpage37
dc.identifier.urihttps://hdl.handle.net/11421/9505
dc.identifier.urihttps://doi.org/10.14748/bmr.v2.210
dc.identifier.volume2
dc.language.isoen
dc.relation.ispartofBiomedical Reviews
dc.rightsopenAccess
dc.subjectDegranulation
dc.subjectVasoactive intestinal peptide
dc.subjectHistamine
dc.subjectEndogeny
dc.subjectMedicine
dc.subjectCompound 48/80
dc.subjectShock (circulatory)
dc.subjectMast cell
dc.subject(+)-Naloxone
dc.subjectImmunology
dc.subjectPharmacology
dc.subjectInternal medicine
dc.subjectNeuropeptide
dc.subjectReceptor
dc.subjectOpioid
dc.subject.sdg3
dc.titleMast cells, vasoactive intestinal peptide (VIP), and the hemorrhagic shock: a possible relationship?
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5036918993

Dosyalar

Koleksiyonlar